AAAAAA

   
Results: 1-22 |
Results: 22

Authors: VANDENBRANDEN M WRIGHTON SA EKINS S GILLESPIE JS BINKLEY SN RING BJ GADBERRY MG MULLINS DC STROM SC JENSEN CB
Citation: M. Vandenbranden et al., ALTERATIONS OF THE CATALYTIC ACTIVITIES OF DRUG-METABOLIZING-ENZYMES IN CULTURES OF HUMAN LIVER SLICES, Drug metabolism and disposition, 26(11), 1998, pp. 1063-1068

Authors: EHLHARDT WJ WOODLAND JM BAUGHMAN TM VANDENBRANDEN M WRIGHTON SA KROIN JS NORMAN BH MAPLE SR
Citation: Wj. Ehlhardt et al., LIQUID-CHROMATOGRAPHY NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY AND LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY IDENTIFICATION OF NOVEL METABOLITES OF THE MULTIDRUG-RESISTANCE MODULATOR LY335979 IN RAT BILE AND HUMAN LIVER MICROSOMAL INCUBATIONS, Drug metabolism and disposition, 26(1), 1998, pp. 42-51

Authors: EKINS S VANDENBRANDEN M RING BJ GILLESPIE JS YANG TJ GELBOIN HV WRIGHTON SA
Citation: S. Ekins et al., FURTHER CHARACTERIZATION OF THE EXPRESSION IN LIVER AND CATALYTIC ACTIVITY OF CYP2B6, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1253-1259

Authors: PECTOR V CASPERS J BANERJEE S DERIEMAEKER L FUKS R ELOUAHABI A VANDENBRANDEN M FINSY R RUYSSCHAERT JM
Citation: V. Pector et al., PHYSICOCHEMICAL CHARACTERIZATION OF A DOUBLE LONG-CHAIN CATIONIC AMPHIPHILE (VECTAMIDINE) BY MICROELECTROPHORESIS, Biochimica et biophysica acta. Biomembranes, 1372(2), 1998, pp. 339-346

Authors: EKINS S VANDENBRANDEN M RING BJ WRIGHTON SA
Citation: S. Ekins et al., EXAMINATION OF PURPORTED PROBES OF HUMAN CYP2B6, Pharmacogenetics, 7(3), 1997, pp. 165-179

Authors: ELOUAHABI A THIRY M PECTOR V FUKS R RUYSSCHAERT JM VANDENBRANDEN M
Citation: A. Elouahabi et al., THE ROLE OF ENDOSOME DESTABILIZING ACTIVITY IN THE GENE-TRANSFER PROCESS MEDIATED BY CATIONIC LIPIDS, FEBS letters, 414(2), 1997, pp. 187-192

Authors: SASAKI S FUKUSHIMA J ARAI H KUSAKABE KI HAMAJIMA K ISHII N HIRAHARA F OKUDA K KAWAMOTO S RUYSSCHAERT JM VANDENBRANDEN M WAHREN B OKUDA K
Citation: S. Sasaki et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC IMMUNE-RESPONSES INDUCEDBY DNA VACCINATION ARE GREATLY ENHANCED BY MANNAN-COATED DIC14-AMIDINE, European Journal of Immunology, 27(12), 1997, pp. 3121-3129

Authors: VANDENBRANDEN M RING BJ BINKLEY SN WRIGHTON SA
Citation: M. Vandenbranden et al., INTERACTION OF HUMAN LIVER CYTOCHROMES P450 IN-VITRO WITH LY307640, AGASTRIC PROTON PUMP INHIBITOR, Pharmacogenetics, 6(1), 1996, pp. 81-91

Authors: RING BJ BINKLEY SN VANDENBRANDEN M WRIGHTON SA
Citation: Bj. Ring et al., IN-VITRO INTERACTION OF THE ANTIPSYCHOTIC AGENT OLANZAPINE WITH HUMANCYTOCHROMES P450 CYP2C9, CYP2C19, CYP2D6 AND CYP3A, British journal of clinical pharmacology, 41(3), 1996, pp. 181-186

Authors: WRIGHTON SA VANDENBRANDEN M RING BJ
Citation: Sa. Wrighton et al., THE HUMAN DRUG-METABOLIZING CYTOCHROMES P450, Journal of pharmacokinetics and biopharmaceutics, 24(5), 1996, pp. 461-473

Authors: HAEHNER BD GORSKI JC VANDENBRANDEN M WRIGHTON SA JANARDAN SK WATKINS PB HALL SD
Citation: Bd. Haehner et al., BIMODAL DISTRIBUTION OF RENAL CYTOCHROME-P450 3A ACTIVITY IN HUMANS, Molecular pharmacology, 50(1), 1996, pp. 52-59

Authors: ELOUAHABI A PECTOR V FUKS R VANDENBRANDEN M RUYSSCHAERT JM
Citation: A. Elouahabi et al., DOUBLE LONG-CHAIN AMIDINE LIPOSOME-MEDIATED SELF-REPLICATING RNA TRANSFECTION, FEBS letters, 380(1-2), 1996, pp. 108-112

Authors: WRIGHTON SA RING BJ VANDENBRANDEN M
Citation: Sa. Wrighton et al., THE USE OF IN-VITRO METABOLISM TECHNIQUES IN THE PLANNING AND INTERPRETATION OF DRUG SAFETY STUDIES, Toxicologic pathology, 23(2), 1995, pp. 199-208

Authors: HALL SD HAMMAN MA RETTIE AE WIENKERS LC TRAGER WF VANDENBRANDEN M WRIGHTON SA
Citation: Sd. Hall et al., RELATIONSHIPS BETWEEN THE LEVELS OF CYTOCHROME P4502C9 AND ITS PROTOTYPIC CATALYTIC ACTIVITIES IN HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 22(6), 1994, pp. 975-978

Authors: DECROLY E VANDENBRANDEN M RUYSSCHAERT JM COGNIAUX J JACOB GS HOWARD SC MARSHALL G KOMPELLI A BASAK A JEAN F LAZURE C BENJANNET S CHRETIEN M DAY R SEIDAH NG
Citation: E. Decroly et al., THE CONVERTASES FURIN AND PC1 CAN BOTH CLEAVE THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 ENVELOPE GLYCOPROTEIN GP160 INTO GP120 (HIV-I SU) AND GP41 (HIV-I TM), The Journal of biological chemistry, 269(16), 1994, pp. 12240-12247

Authors: GORSKI JC HALL SD VANDENBRANDEN M WRIGHTON SA JONES DR
Citation: Jc. Gorski et al., REGIOSELECTIVE BIOTRANSFORMATION OF MIDAZOLAM BY MEMBERS OF THE HUMANCYTOCHROME-P450-3A (CYP3A) SUBFAMILY, Biochemical pharmacology, 47(9), 1994, pp. 1643-1653

Authors: RUYSSCHAERT JM ELOUAHABI A WILLEAUME V HUEZ G FUKS R VANDENBRANDEN M DISTEFANO P
Citation: Jm. Ruysschaert et al., A NOVEL CATIONIC AMPHIPHILE FOR TRANSFECTION OF MAMMALIAN-CELLS, Biochemical and biophysical research communications, 203(3), 1994, pp. 1622-1628

Authors: WRIGHTON SA VANDENBRANDEN M STEVENS JC SHIPLEY LA RING BJ RETTIE AE CASHMAN JR
Citation: Sa. Wrighton et al., IN-VITRO METHODS FOR ASSESSING HUMAN HEPATIC DRUG-METABOLISM - THEIR USE IN DRUG DEVELOPMENT, Drug metabolism reviews, 25(4), 1993, pp. 453-484

Authors: STEVENS JC SHIPLEY LA CASHMAN JR VANDENBRANDEN M WRIGHTON SA
Citation: Jc. Stevens et al., COMPARISON OF HUMAN AND RHESUS-MONKEY IN-VITRO PHASE-I AND PHASE-II HEPATIC DRUG-METABOLISM ACTIVITIES, Drug metabolism and disposition, 21(5), 1993, pp. 753-760

Authors: DECROLY E CORNET B MARTIN I RUYSSCHAERT JM VANDENBRANDEN M
Citation: E. Decroly et al., SECONDARY STRUCTURE OF GP160 AND GP120 ENVELOPE GLYCOPROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - A FOURIER-TRANSFORM INFRARED SPECTROSCOPIC STUDY, Journal of virology, 67(6), 1993, pp. 3552-3560

Authors: WRIGHTON SA STEVENS JC BECKER GW VANDENBRANDEN M
Citation: Sa. Wrighton et al., ISOLATION AND CHARACTERIZATION OF HUMAN LIVER CYTOCHROME-P450 2C19 - CORRELATION BETWEEN 2C19 AND S-MEPHENYTOIN-4'-HYDROXYLATION, Archives of biochemistry and biophysics, 306(1), 1993, pp. 240-245

Authors: WRIGHTON SA VANDENBRANDEN M BECKER GW BLACK SD THOMAS PE
Citation: Sa. Wrighton et al., 2 MONOCLONAL-ANTIBODIES RECOGNIZING DIFFERENT EPITOPES ON RAT CYTOCHROME IIB1 REACT WITH HUMAN IIE1, Molecular pharmacology, 41(1), 1992, pp. 76-82
Risultati: 1-22 |